Home > Insider Trading > Filing (0001225208-19-004612)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
78003	Pfizer Inc	PFE	Pharmaceutical Preparations (2834)	135315170

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1437590	Mikael Dolsten	Pfizer Inc.-Corp. Secretary 235 East 42Nd St. New York NY 10017	President R&D	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2019-03-01	57,609	$30.59	390,097	No	4	M	Direct
Common Stock	Acquisiton	2019-03-01	48,582	$32.23	438,679	No	4	M	Direct
Common Stock	Disposition	2019-03-01	2,300	$43.59	436,379	No	4	S	Direct
Common Stock	Disposition	2019-03-01	5,927	$43.58	430,452	No	4	S	Direct
Common Stock	Disposition	2019-03-01	14,760	$43.57	415,692	No	4	S	Direct
Common Stock	Disposition	2019-03-01	77,484	$43.56	338,208	No	4	S	Direct
Common Stock	Disposition	2019-03-04	2,187	$43.56	336,021	No	4	S	Direct
Common Stock	Disposition	2019-03-04	2,400	$43.55	333,621	No	4	S	Direct
Common Stock	Disposition	2019-03-04	2,600	$43.54	331,021	No	4	S	Direct
Common Stock	Disposition	2019-03-04	3,250	$43.53	327,771	No	4	S	Direct
Common Stock	Disposition	2019-03-04	38,645	$43.52	289,126	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Appreciation Rights	Disposition	2019-03-01	155,172	$0.00	155,172	$30.59
Common Stock	Stock Appreciation Rights	Disposition	2019-03-01	126,366	$0.00	126,366	$32.23

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2019-02-25	2021-02-25	No	4	M	Direct
0	2018-06-16	2021-02-27	No	4	M	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock	1,625	Indirect	By Rule 16b-3 Plan

Footnotes

Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $42.45)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the fifth anniversary of grant.
Represents the number of stock units received upon the exercise and conversion of previously granted stock appreciation rights (SARs), calculated by taking the change in our common stock price (20 trading day average ending on the exercise date (Election Price of $42.45)) less the grant price of the SAR plus accumulated dividends from the grant date, times the number of SARs exercised. This value is divided by the Election Price to determine the number of stock units. The stock units and accumulated dividend units will be settled in Pfizer common stock on the SAR original settlement date, the seventh anniversary of grant.